+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
The market size for brain aneurysm treatment was US$ 2,137 Mn in 2019. From 2020 to 2028, it will reach US$ 6, 156.22 Mn with a CAGR of 13.9% during forecast.
Download Free Report Sample to learn more about this report.
A brain aneurysm is a bulging in the arteries of the brain. The strain on the nerves and brain tissues is caused by the bulging. This protrusion has the potential to rupture or burst, resulting in cerebral bleeding and death. Aneurysms in the brain are caused by a variety of circumstances including hereditary disorders, arteriovenous malformations, untreated high blood pressure, and smoking. The global brain aneurysm treatment market is growing due to the rising number of brain aneurysm cases and the associated risks.
Furthermore, increasing research and development efforts in the field of brain and neurological disorders are expected to propel the brain aneurysm market forward throughout the projected period. According to the brain aneurysm estimation, Unruptured brain aneurysms have an impact on around 6.5 million people in the United States, or one in every 50 people.
The annual rupture rate ranges from 8 to 10 per 100,000 persons. In addition, in December 2019, Kaneka introduced a novel coil for brain aneurysm embolization a Japanese international chemical manufacturing company, announced by maximizing the metal wire diameter, which is the raw material for embolization coils, and adding innovative construction processes, Kaneka has produced a product that takes coil flexibility to the greatest level in the world. The rising healthcare infrastructure and rapidly increasing screening tests for brain aneurysm in Asia Pacific are predicted to generate a profitable potential for brain aneurysm treatment market expansion.
The rise in the prevalence of brain aneurysms
The prevalence of brain aneurysms is expected to rise due to an increase in the number of related risk factors, which would finally enhance the growth of the brain aneurysm treatment market during the projected period. Cerebral aneurysms affect 3.2 percent of the world's population, with the average age of onset being 50 years. According to scientists, approximately 6 million Americans have a brain aneurysm that hasn't burst, with roughly 30,000 of them rupturing each year. The patient dies in 40 out of every hundred ruptures.
Advances in surgical equipment and procedures will create additional prospects for the aneurysm treatment industry to flourish.
Medical science has developed new drugs, devices and equipment allowing impressive advances in brain aneurysm treatment. Socially, patients’ standards of living have risen with consequent improvement in living conditions, communications and transport. As a result, the scope of brain aneurysm treatment has widened to include sicker patients undergoing more complex surgery from a greater cross-section of the population.
During the projection period, however, the high cost of brain aneurysm therapy surgery is expected to stymie brain aneurysm treatment market expansion. The high cost of surgical treatments, is expected to have a negative influence on market growth throughout the projection period.
Lack of awareness regarding developing regions
Rise in Research and Development Activities
Several healthcare organisations and industry players are using good strategies to boost brain aneurysm therapeutic research and development. For example, in August 2019, Fujitsu Australia, Macquarie Medical Imaging, Macquarie University, and GE Healthcare formed a new research alliance to investigate creative ways to enhance the detection of brain aneurysms. According to the organisation, it will focus on the usage and deployment of artificial intelligence to identify and analyse brain aneurysms.
Download Free Report Sample to learn more about this report.
Brain Aneurysm Treatment Market Analysis by Treatment:
Based on the type, the Brain Aneurysm Treatment Market is primarily split into Medication and Surgery. Brain Aneurysm Treatment Market growing with high CAGR during forecast period.
Market Analysis by Type:
Based on the Brain Aneurysm Treatment Market by Type, the Brain Aneurysm Treatment Marketis segmented into several major parts, like Aortic Aneurysm, Cerebral Aneurysm and Others.
Market Analysis by Administration:
Based on the Brain Aneurysm Treatment Market by administration consists Oral, Injectable and Others.
North America holds the highest market share driven mostly by large population base in China & Indian region. As per latest market news the increasing industry development in this sector many companies are showing interest in investing in this brain aneurysm treatment market.
During the study, Research Layer analyzed some of the major players in the global brain aneurysm treatment market who have contributed to the market growth. These include Medtronic, Integra LifeSciences, Raumedic, InfraScan,Sophysa, MicroPort, Head Sense Medical, Spiegelberg, Johnson & Johnson.
August 2020, Carondelet St. Joseph’s Hospital a neurological Institute opens study of brain aneurysm stent. The FDA trial will be one of the largest prospective cerebral aneurysm stent trials till date, as per to Dr. Coon. The study is taking place at 40 sites in Canada, the United States, and Australia.
January 2020 MicroVention, Inc A Terumo subsidiary established in the United States and a global neurovascular company, announced that the FREDTM (Flow Redirection Endoluminal Device) device for the treatment of brain aneurysms has received FDA Premarket Approval (PMA). The FREDTM device is the first flow diverter in the United States to employ a self-expanding braided nitinol mesh to aid in blood flow rerouting and aneurysm occlusion.
This report forecasts revenue growth at regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017-2028. For the purpose of this study, Research Layer has segmented the Brain Aneurysm Treatment Market based on treatment, type administration, and region:
Report Scope
Asia Pacific holds the Largest market share in regional segment.
As per Research Layer the global Brain Aneurysm Treatment Market size was 2,137 US Dollars in 2019 to 6, 156.22 US Dollars by 2028.
Top key players in the global Brain Aneurysm Treatment Market are Medtronic, Integra LifeSciences, Raumedic, InfraScan, Sophysa, MicroPort, Head Sense Medical, Spiegelberg, TJohnson & Johnson
The market is expected to grow CAGR of 13.9% during forecast period.
By Type, Application and Region segments are covered in Brain Aneurysm Treatment Market Report.
Report Code :
RL655
Published on :
Aug 2022
Request a Free Sample Report
Speak to Analyst